Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Voting Results Of National Company Law Tribunal ('NCLT") Convened Meeting Of The Equity Shareholders Of Sun Pharmaceutical Industries Limited ('The Company') Held On June 01, 2018

 Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, enclose herewith the details of the result of remote e-voting and electronic voting system conducted at the NCLT convened meeting of equity shareholders of the Company held on Friday, June 01, 2018
02-06-2018
Bigul

Proceedings Of National Company Law Tribunal Convened Separate Meetings Of The Equity Shareholders And Unsecured Creditors Of Sun Pharmaceutical Industries Limited Held On June 01, 2018

 Proceedings of National Company Law Tribunal convened separate meetings of the equity shareholders and unsecured creditors of Sun Pharmaceutical Industries Limited held on June 01, 2018
01-06-2018
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Sudhir Valia
28-05-2018
Bigul

Forget Sun Pharma, never buy leader of previous bull mkt

 We chase alpha and we manage risks. You would not get a 40-50 compounder again in Sun Pharma.
28-05-2018
Bigul

Sun Pharma Q4 consolidated net profit up 7% at Rs 13 billion

 The company had reported a net profit of Rs 12.23 billion in the same period of the previous financial year.
25-05-2018
Bigul

Sun Pharma Reports Q4 & FY18 Results

 Press Release relating to fourth quarter & full year FY18 financials, which we shall be releasing after sending this letter to you. This is for your information and record.
25-05-2018
Bigul

Board recommends Dividend

 Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2018, inter alia, has recommended payment of dividend of Rs. 2/- (Rupees Two Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2018, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.The dividend is expected to be paid on or about last week of September, 2018.
25-05-2018
Bigul

Announcement under Regulation 30 (LODR)-Scheme of Arrangement

 Outcome of Board Meeting held on May 25, 2018 - Approved the Composite Scheme of Arrangement among Sun Pharmaceutical Industries Limited ('Transferor Company') and Sun Pharma (Netherlands) B.V. ('Transferee Company 1') and Sun Pharmaceutical Holdings USA Inc. ('Transferee Company 2') and their respective members and creditors
25-05-2018
Bigul

Board Meeting-Outcome of Board Meeting

 Recommended dividend of Rs.2/- (Rupees Two Only) per equity share of Re.1/- each of the Company for the year ended March 31, 2018.
25-05-2018
Bigul

Board Meeting-Outcome of Board Meeting

 Outcome of the Board Meeting of the Company held on May 25, 2018
25-05-2018
Next Page
Close

Let's Open Free Demat Account